Colgate-Palmolive Company (CL) : Ramsay Stattman Vela Price reduced its stake in Colgate-Palmolive Company by 4.94% during the most recent quarter end. The investment management company now holds a total of 99,795 shares of Colgate-Palmolive Company which is valued at $7.2 Million after selling 5,190 shares in Colgate-Palmolive Company , the firm said in a disclosure report filed with the SEC on May 11, 2016.Colgate-Palmolive Company makes up approximately 3.71% of Ramsay Stattman Vela Price’s portfolio.
Other Hedge Funds, Including , Cornerstone Capital Management Holdings. reduced its stake in CL by selling 1,884 shares or 0.87% in the most recent quarter. The Hedge Fund company now holds 215,108 shares of CL which is valued at $15.4 Million. Colgate-Palmolive Company makes up approx 0.13% of Cornerstone Capital Management Holdings.’s portfolio.Cornerstone Financial Partners reduced its stake in CL by selling 1,922 shares or 31.95% in the most recent quarter. The Hedge Fund company now holds 4,093 shares of CL which is valued at $293,959. Colgate-Palmolive Company makes up approx 0.11% of Cornerstone Financial Partners’s portfolio.Northeast Investment Management boosted its stake in CL in the latest quarter, The investment management firm added 88 additional shares and now holds a total of 85,153 shares of Colgate-Palmolive Company which is valued at $6.1 Million. Colgate-Palmolive Company makes up approx 0.62% of Northeast Investment Management’s portfolio.Checchi Capital Advisers reduced its stake in CL by selling 288 shares or 3.9% in the most recent quarter. The Hedge Fund company now holds 7,099 shares of CL which is valued at $509,850. Colgate-Palmolive Company makes up approx 0.14% of Checchi Capital Advisers’s portfolio.
Colgate-Palmolive Company opened for trading at $71.59 and hit $72.22 on the upside on Monday, eventually ending the session at $72.02, with a gain of 0.49% or 0.35 points. The heightened volatility saw the trading volume jump to 21,43,404 shares. Company has a market cap of $64,315 M.
On the company’s financial health, Colgate-Palmolive Company reported $0.63 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.63. The company had revenue of $3762.00 million for the quarter, compared to analysts expectations of $3760.63 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.66 EPS.
Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by Goldman to ” Neutral” on May 2, 2016. Company shares were Reiterated by UBS on Apr 29, 2016 to “Neutral”, Firm has raised the Price Target to $ 76 from a previous price target of $73 .Colgate-Palmolive Company was Downgraded by Sterne Agee CRT to ” Neutral” on Feb 26, 2016.
Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.